Connacht Asset Management LP Tandem Diabetes Care Inc Transaction History

Connacht Asset Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $74,295 - $171,833	1,396 Added 25.57%	6,856 $406,000
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $138,468 - $203,972	1,359 Added 33.14%	5,460 $635,000
Q4 2021 Feb 11, 2022	BUY	$118.18 - $153.21 $170,297 - $220,775	1,441 Added 54.17%	4,101 $617,000
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $97,998 - $135,611	-1,048 Reduced 28.26%	2,660 $318,000
Q2 2021 Aug 16, 2021	BUY	$77.0 - $100.19 $285,516 - $371,504	3,708 New	3,708 $361,000

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.